Latest News & Updates
Breaking News
3 hours ago
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Pharma Now Editorial Team
Other trending news you may like to read
NKGen Biotech Activates Three U.S. Sites for Phase 2 Troculeucel Trial in Moderate Alzheimer's Disease
NKGen Biotech adds three U.S. sites to its Phase 2 troculeucel trial, raising GMP batch demand questions for autologous NK cell manufacturing.
Pharma Now Editorial Team
Novo Nordisk Presents Semaglutide MASH Data at EASL 2026 Across Three Patient Subgroups
Novo Nordisk presents ESSENCE subgroup data at EASL 2026, extending semaglutide's MASH evidence to Japanese patients and postmenopausal women.
Pharma Now Editorial Team
Zeus Hygia Launches Metaberine® in Europe and US Markets Targeting Metabolic Health
Zeus Hygia launches Metaberine® in the US and Europe using BioSOLVE Technology, targeting metabolic health under two distinct regulatory regimes.
Pharma Now Editorial Team
HAB Pharma Merges with Signature Phytochemicals to Form Rs. 600 Crore Integrated Manufacturer
HAB Pharma and Signature Phytochemicals merge into a Rs. 600 crore entity, targeting Rs. 3,000 crore revenue by 2030 with sterile and OSD plants due August 2026.
Pharma Now Editorial Team
